There is an urgent need for new antimicrobial agents because antibiotic resistance has become so prevalent. But a promising class of such agents, known as RAMPs, may suffer from the same problem.
This is a preview of subscription content
Access options
Subscribe to Journal
Get full journal access for 1 year
$199.00
only $3.90 per issue
All prices are NET prices.
VAT will be added later in the checkout.
Tax calculation will be finalised during checkout.
Buy article
Get time limited or full article access on ReadCube.
$32.00
All prices are NET prices.
References
Perron, G. G., Zasloff, M. & Bell, G. Proc. R. Soc. Lond. B doi:rspb.2005.3301 (2005).
Zasloff, M. Nature 415, 389–395 (2002).
Mygind, P. H. et al. Nature 437, 975–980 (2005).
Bell, G. & Gouyon, P. -H. Microbiology 149, 1367–1375 (2003).
Trevor, F. C. & McDonald, L. C. Curr. Opin. Infect. Dis. 18, 300–305 (2005).
Ge, Y. et al. Antimicrob. Agents Chemother. 43, 782–788 (1999).
Steinberg, D. A. et al. Antimicrob. Agents Chemother. 41, 1738–1742 (1997).
Maisnier-Patin, S. & Andersson, D. S. Res. Microbiol. 150, 360–369 (2004).
Schrag, S. J. et al. Proc. R. Soc. Lond. B 264, 1287–1291 (1997).
Fedtke, I., Gotz, F. & Peschel, A. Int. J. Med. Microbiol. 294, 189–194 (2004).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Buckling, A., Brockhurst, M. RAMP resistance. Nature 438, 170–171 (2005). https://doi.org/10.1038/438170a
Published:
Issue Date:
DOI: https://doi.org/10.1038/438170a